OpenVSafe by OpenVAERS
Search V-safe

L9U-16553-79778

2 vaccinations 2 coded responses 25 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
21-25
ZIP prefix
492 / MI
Registered
2021-02-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-04
    Registered in v-safe
  2. 2021-02-04
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-04
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-02-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-02-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-11
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-18
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-25
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-25
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Nausea · Be unable to work
    Adult check-in
  15. 2021-02-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling, Itching · None
    Adult check-in
  16. 2021-02-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Itching · Headache
    Adult check-in
  17. 2021-03-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  18. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · Headache
    Adult check-in
  19. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  20. 2021-03-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-03-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-27
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-27
    Survey response — 6 months, dose 2
    MedDRA: Nausea, Vomiting — Feeling: Fair · Be unable to work or attend school
    Free text: Vomiting, nausea
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2022-02-25
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous, Epilepsy, Seizure — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Seizures, epilepsy, miscarriage.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-02-25
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  30. 2022-02-28
    Call successful
    Does not wish to fill out VAERS report

Vaccinations

DoseDateManufacturerCo-administered
12021-02-04Pfizer-BioNTech
22021-02-25Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-02-25 Successful
2022-02-28
Does not wish to fill out VAERS report

Free text

Release 9 — 6 months, dose 2

2021-08-27

Symptoms: Vomiting, nausea

Release 11 — 12 months, dose 2

2022-02-25

Symptoms: Seizures, epilepsy, miscarriage.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDEpilepsy · · ✓
SDNausea ✓ · ✓
SDSeizure · · ✓
SDVomiting ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release